(IMAX) Imax - NYSE
Sector: Communication Services | Industry: Entertainment | Exchange: NYSE (USA) | Market Cap: 2.437m USD | Total Return: 51.8% in 12m
Avg Turnover: 38.5M
EPS Trend: 82.0%
Qual. Beats: 0
Rev. Trend: 48.1%
Qual. Beats: 0
Warnings
Altman Z'' 0.99 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
IMAX Corporation operates as a global entertainment technology provider specializing in proprietary cinematic formats and distribution systems. The company’s business model revolves around the Content Solutions and Technology Products segments, which encompass film remastering (DMR), theater system sales and leases, and specialized camera rentals for content creators. Beyond traditional cinema, the firm has expanded into AI-driven video quality software and home entertainment through its IMAX Enhanced initiative.
The company functions primarily as a technology licensor rather than a traditional theater operator, allowing it to maintain an asset-light model while capturing a percentage of box office revenue from its global network. The premium large format (PLF) sector currently benefits from a structural shift in consumer behavior toward high-end, experiential viewing over standard cinema screenings. For a deeper look at how these licensing dynamics impact valuation, review the latest metrics on ValueRay.
IMAX maintains a diverse distribution footprint across educational institutions, commercial multiplexes, and private home theaters. Its revenue streams are diversified through maintenance services, post-production support, and the distribution of documentary and live event content. This integrated approach positions the firm as a critical infrastructure provider for both Hollywood studios and international exhibitors.
- Global box office performance of Hollywood and local language blockbuster film titles
- Expansion of theater network footprint through joint revenue sharing and sales arrangements
- Growth in high-margin digital remastering revenue from proprietary film post-production services
- Adoption of IMAX Enhanced and AI video technology in home streaming markets
- Fluctuations in Chinese consumer cinema attendance and regional geopolitical regulatory risks
| Net Income: 36.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 6.66 > 1.0 |
| NWC/Revenue: 20.30% < 20% (prev 85.30%; Δ -65.00% < -1%) |
| CFO/TA 0.14 > 3% & CFO 123.9m > Net Income 36.8m |
| Net Debt (144.8m) to EBITDA (126.6m): 1.14 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.4m) vs 12m ago 2.59% < -2% |
| Gross Margin: 58.11% > 18% (prev 54.62%; Δ 3.49% > 0.5%) |
| Asset Turnover: 46.50% > 50% (prev 42.41%; Δ 4.10% > 0%) |
| Interest Coverage Ratio: 8.56 > 6 (EBIT TTM 63.8m / Interest Expense TTM 7.46m) |
| A: 0.09 (Total Current Assets 290.4m - Total Current Liabilities 208.2m) / Total Assets 893.2m |
| B: -0.26 (Retained Earnings -235.7m / Total Assets 893.2m) |
| C: 0.07 (EBIT TTM 63.8m / Avg Total Assets 870.7m) |
| D: 0.72 (Book Value of Equity 335.5m / Total Liabilities 464.8m) |
| Altman-Z'' = 0.99 = BB |
| DSRI: 0.30 (Receivables 108.5m/325.4m, Revenue 404.9m/359.8m) |
| GMI: 0.94 (GM 54.62% / 58.11%) |
| AQI: 2.55 (AQ_t 0.41 / AQ_t-1 0.16) |
| SGI: 1.13 (Revenue 404.9m / 359.8m) |
| TATA: -0.10 (NI 36.8m - CFO 123.9m) / TA 893.2m) |
| Beneish M = -2.66 (Cap -4..+1) = A |
As of June 20, 2026, the stock is trading at USD 44.33 with a total of 674,456 shares traded.
Over the past week, the price has changed by +5.25%,
over one month by +29.43%,
over three months by +18.34% and
over the past year by +51.82%.
Imax has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy IMAX.
- StrongBuy: 7
- Buy: 2
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 47.2 | 6.4% |
P/E Trailing = 66.1045
P/E Forward = 26.8097
P/S = 6.0176
P/B = 7.2636
P/EG = 0.8895
Revenue TTM = 404.9m USD
EBIT TTM = 63.8m USD
EBITDA TTM = 126.6m USD
Long Term Debt = 244.1m USD (from longTermDebt, last quarter)
Short Term Debt = 46.7m USD (from shortTermDebt, last quarter)
Debt = 290.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 144.8m USD (calculated: Debt 290.8m - CCE 146.0m)
Enterprise Value = 2.58b USD (2.44b + Debt 290.8m - CCE 146.0m)
Interest Coverage Ratio = 8.56 (Ebit TTM 63.8m / Interest Expense TTM 7.46m)
EV/FCF = 22.39x (Enterprise Value 2.58b / FCF TTM 115.3m)
FCF Yield = 4.47% (FCF TTM 115.3m / Enterprise Value 2.58b)
FCF Margin = 28.47% (FCF TTM 115.3m / Revenue TTM 404.9m)
Net Margin = 9.08% (Net Income TTM 36.8m / Revenue TTM 404.9m)
Gross Margin = 58.11% ((Revenue TTM 404.9m - Cost of Revenue TTM 169.6m) / Revenue TTM)
Gross Margin QoQ = 56.29% (prev 55.99%)
Tobins Q-Ratio = 2.89 (Enterprise Value 2.58b / Total Assets 893.2m)
Interest Expense / Debt = 2.56% (Interest Expense 7.46m / Debt 290.8m)
Taxrate = 22.90% (12.9m / 56.4m)
NOPAT = 49.2m (EBIT 63.8m * (1 - 22.90%))
Current Ratio = 1.39 (Total Current Assets 290.4m / Total Current Liabilities 208.2m)
Debt / Equity = 0.87 (Debt 290.8m / totalStockholderEquity, last quarter 335.5m)
Debt / EBITDA = 1.14 (Net Debt 144.8m / EBITDA 126.6m)
Debt / FCF = 1.26 (Net Debt 144.8m / FCF TTM 115.3m)
Total Stockholder Equity = 335.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.22% (Net Income 36.8m / Total Assets 893.2m)
RoE = 10.95% (Net Income TTM 36.8m / Total Stockholder Equity 335.8m)
RoCE = 11.00% (EBIT 63.8m / Capital Employed (Equity 335.8m + L.T.Debt 244.1m))
RoIC = 6.92% (NOPAT 49.2m / Invested Capital 711.4m)
WACC = 7.20% (E(2.44b)/V(2.73b) * Re(7.82%) + D(290.8m)/V(2.73b) * Rd(2.56%) * (1-Tc(0.23)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 77.78 | Cagr: 1.13%
[DCF] Terminal Value 77.97% ; FCFF base≈90.4m ; Y1≈103.6m ; Y5≈152.5m
[DCF] Fair Price = 39.08 (EV 2.29b - Net Debt 144.8m = Equity 2.15b / Shares 55.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 82.00 | EPS CAGR: 25.82% | SUE: 0.40 | # QB: 0
Revenue Correlation: 48.09 | Revenue CAGR: 2.98% | SUE: 0.21 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.32 | Chg30d=-2.70% | Revisions=-25% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.50 | Chg30d=+0.00% | Revisions=+11% | Analysts=8
EPS current Year (2026-12-31): EPS=1.69 | Chg30d=-0.51% | Revisions=-14% | GrowthEPS=+16.6% | GrowthRev=+7.5%
EPS next Year (2027-12-31): EPS=1.95 | Chg30d=+0.00% | Revisions=-20% | GrowthEPS=+15.4% | GrowthRev=+6.9%
[Analyst] Revisions Ratio: -25%